Plasma Proteomic Analysis Based on 4D-DIA Evaluates the Clinical Response to Imrecoxib in the Early Treatment of Osteoarthritis

ConclusionThis study successfully identified biomarkers for evaluating imrecoxib ’s clinical response in patients with OA using 4D-DIA technology. These biomarkers may play a vital role in future personalized OA treatment strategies, pending further confirmation.
Source: Rheumatology and Therapy - Category: Rheumatology Source Type: research